Cellares CEO discusses its recent fund raise and Cell Shuttle impact in cell therapy manufacturing
Vložit
- čas přidán 8. 01. 2024
- Fabian Gerlinghaus, CEO of Cellares, discusses the company's recent $255M Series C funding, the impact of their Cell Shuttle in cell therapy manufacturing, and the growth of strategic partnerships on #NYSEFloorTalk with Judy Khan Shaw.